Prime Medicine Inc. (PRME)
NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 7, 3:27 PM ET
PRME stock chart
Technical analysisKey statistics
All statistics- Market cap
- $722.79M
- EPS (TTM)
- -$1.07
- Dividend yield
- None
- 52-week range
- 2.67 – 6.85
- Day range
- 3.30 – 4.02
- Volume / Avg
- 8.84M / 3.32M
- Beta
- —
- Shares outstanding
- 181.38M
- Next earnings
- Nov 6, 2026
52-week range
PRME stock today
On Oct 7, PRME is trading at $3.99, adding $0.485 (13.86%), versus the S&P 500's 0.25% decline. Volume was 2.7x the average at 8.84M shares, a sign of unusually heavy trading. At this level, PRME sits in the middle of its 52-week range of $2.67 to $6.85: 41.8% below the high and 49.3% above the low.
Prime Medicine has posted a net loss over the last twelve months (EPS of -$1.07), so its P/E ratio is not meaningful. Prime Medicine's next earnings report is expected on Nov 6, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Prime Medicine
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- IPO year
- 2022
Earnings
Earnings history- Next report
- Nov 6, 2026
- EPS estimate
- $-0.23
Prime Medicine peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PROKProKidney Corp. Class A | 1.58 | -1.56% | $628.71M | vs PRME |
| DBVTDBV Technologies S.A. ADR | 9.86 | -1.20% | $619.69M | vs PRME |
| AURAAura Biosciences Inc. | 6.47 | +4.86% | $670.97M | vs PRME |
| FDMT4D Molecular Therapeutics Inc. | 12.61 | +0.40% | $696.63M | vs PRME |
| ETRAElectra Therapeutics Inc. | 9.08 | -7.54% | $569.92M | vs PRME |
| VALNValneva SE ADR | 5.92 | +0.94% | $560.88M | vs PRME |
| SLDBSolid Biosciences Inc. | 6.81 | -1.59% | $730.20M | vs PRME |
| CADLCandel Therapeutics Inc. | 9.73 | -1.42% | $744.53M | vs PRME |
Indexes, lists and sector
Largest Health Care stocks
Prime Medicine stock FAQ
What is Prime Medicine's stock price today?
PRME last traded at $3.99 as of Oct 7, 3:27 PM EDT, up 13.86% on the day. Prices are delayed at least 15 minutes.
When is Prime Medicine's next earnings date?
Prime Medicine is expected to report earnings on Friday, November 6, 2026. Analysts expect EPS of $-0.23.
What is the PRME 52-week high?
The 52-week high for PRME is $6.85 and the 52-week low is $2.67. The stock is currently 41.8% below its high.